109
Consolidated Income Statement
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2021
Note | 2021 | 2020 | |||
$'000 | $'000 | ||||
Revenue | 4 | 685,710 | 726,561 | ||
Cost of sales | 7 | (512,107) | (559,334) | ||
Gross profit | 173,603 | 167,227 | |||
Other income | 5 | 4,765 | 6,473 | ||
Other gains - net | 6 | 127,700 | 895 | ||
Impairment loss on financial assets and contract assets | 38(b) | (1,527) | (3,393) | ||
Expenses | (37,997) | ||||
- | Selling and distribution | 7 | (37,894) | ||
- | Administrative | 7 | (71,015) | (63,456) | |
- | Finance | 9 | (3,835) | (5,213) | |
Share of profit/(loss) of associates and joint ventures | 10 | 12,601 | (1,599) | ||
Profit before income tax | 204,295 | 63,040 | |||
Income tax expense | 11 | (25,440) | (18,581) | ||
Total profit | 178,855 | 44,459 | |||
Profit attributable to: | 113,073 | ||||
Equity holders of the Company | 30,872 | ||||
Non-controlling interests | 65,782 | 13,587 | |||
178,855 | 44,459 | ||||
Earnings per share for profit attributable to equity holders of the Company | |||||
(cents per share) | |||||
- | Basic | 12 | 23.27 | 6.30 | |
- | Diluted | 12 | 23.25 | 6.29 |
Overview
Review Strategic
Statements Financial
The accompanying notes form an integral part of these financial statements.